Onco-Innovations Limited
ONCO
| 07/31/2025 | 04/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -38.26% | 0.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -38.26% | 0.00% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -38.26% | 0.00% | |||
| SG&A Expenses | -56.56% | -0.01% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -39.29% | -0.02% | |||
| Operating Income | 39.32% | 0.01% | |||
| Income Before Tax | 31.39% | 0.02% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 31.39% | 0.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 31.39% | 0.02% | |||
| EBIT | 39.32% | 0.01% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 55.66% | 0.00% | |||
| Normalized Basic EPS | 18.73% | 0.00% | |||
| EPS Diluted | 55.66% | 0.00% | |||
| Normalized Diluted EPS | 18.73% | 0.00% | |||
| Average Basic Shares Outstanding | 54.85% | 0.00% | |||
| Average Diluted Shares Outstanding | 54.85% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||